Physician

Alexandru Petre David, M.D.

According to 2025 Medicare claims, Alexandru David, M.D. (NPI: 1427202381) practices infectious disease in the Casper, WY market, with the plurality of this provider's patient population coming from Natrona, WY. This provider's primary affiliated billing organization is ROCKY MOUNTAIN INFECTIOUS DISEASES (NPI: 1497833180; TIN: 830326365) and primary practice location at 82601-2239. David is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

David's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 614 traditional Medicare patients, billed 174,402 HCPCS/CPT codes, and received $336,645 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 252 prescription claims across 121 beneficiaries totaling $84,667 in drug costs, led by Doxycycline Hyclate (Doxycycline Hyclate). 2022 DME data shows 11 claims. Open Payments data shows 1 records totaling $37. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $378,256 and ending at $336,645. Concurrently, Part D prescription costs have declined steadily, from $367,419 to $84,667. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $1,804 and ending at $2,411.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	657	196,750	$378,256
2016	674	81,847	$323,890
2017	703	61,907	$255,547
2018	709	77,907	$251,816
2019	723	118,157	$410,042
2020	712	204,908	$514,536
2021	704	229,342	$532,006
2022	684	191,382	$336,592
2023	673	216,853	$429,734
2024	614	174,402	$336,645

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	96	233	$367,419
2016	97	252	$914,941
2017	121	274	$426,473
2018	128	294	$482,670
2019	98	280	$709,007
2020	90	217	$492,246
2021	78	151	$195,002
2022	90	238	$326,364
2023	105	273	$202,614
2024	121	252	$84,667

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	102	$541
2017	149	558	$3,905
2018	13	61	$334
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	11	$708
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	164	209	$137
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	259	376	$95
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	143	368	$88
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	123	564	$48
36415	Insertion of needle into vein for collection of blood sample	185	306	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Doxycycline Hyclate	Doxycycline Hyclate	38	890	$862
Cephalexin	Cephalexin	25	685	$629
Amoxicillin	Amoxicillin	28	925	$543

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$37	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alexandru Petre David, M.D.?

Tedicare shows public-source Medicare data for Alexandru Petre David, M.D. (NPI 1427202381), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexandru Petre David, M.D. have ACO affiliation data?

Alexandru Petre David, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Alexandru Petre David, M.D.?

Alexandru Petre David, M.D. is linked to ROCKY MOUNTAIN INFECTIOUS DISEASES (billing NPI 1497833180) in the available physician profile data.

Does Alexandru Petre David, M.D. have Open Payments data?

Alexandru Petre David, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.